COSM (Cosmos Health Inc) Forward P/E Multiple

Symbol and logo of brand cosmosholdingsinc.com (COSM)

The forward P/E of the business on the GURU.Markets daily chart illustrates the valuation trend, where the 2.80 mark reflects the latest data. Cosmos Health Inc. (COSM) is building a vertically integrated holding company, combining generic drug production and pharmacy retail in Europe. Growth is driven by AI-powered development of new formulas and the expansion of nutraceutical brands. Modernization relies on autonomous warehouse logistics and the robotization of filling lines.

Projected Price to Earnings Ratio: Cosmos Health (COSM) for 04/28/2023 - 11/11/2026

Cosmos Health Inc (COSM) - metric breakdowns and financial figures

- current price and projected stock value:
Stock Quotes Cosmos Health|COSM - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Cosmos Health, Inc.|COSM - Value Adjusted for Debt and Cash
- book capitalization information:
Net Assets per Single Share Cosmos Health|COSM - Total Stockholders' Equity|Market Value to Book Value Ratio cosmosholdingsinc.com|COSM - Aggregate Company Assets
- debt burden and liquidity indicators:
Total Debt to Capital Cosmos Health Inc.|COSM - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Cosmos Health Inc.|COSM - Company Total Debt Obligations|Debt to Book Capitalization Ratio Cosmos Health, Inc.|COSM - Company Long-Term Indebtedness|Company Short-Term Debts Cosmos Health|Quick Ratio cosmosholdingsinc.com
- company profitability and valuation multiples indicators:
COSM - Net Income|Expected Profit Cosmos Health Inc.|COSM - Market Cap to Earnings|Future Price to Earnings Cosmos Holdings|COSM - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cosmos Health, Inc.|COSM - Operating profit before deduction of amortization|Earnings per share for the last twelve months Cosmos Health|COSM - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months cosmosholdingsinc.com|COSM - Expected net earnings per share growth this year|Expected earnings per share growth for next year Cosmos Health Inc.
Basic company analysis:COSM Cosmos Health
Brand item of Cosmos Health Inc

The development of European distribution and the expansion of dietary supplement brands by Cosmos Health Inc. (COSM) are reflected in the company's forward 12-month P/E ratio, which compares current market capitalization with projected net income. This indicator measures the cost of one dollar of future earnings, allowing investors to assess the premium paid for the asset considering the digitalization costs of the pharmacy business already priced in.

Who Cosmos Health Inc. competes with

Projected Price to Earnings LLY (Eli Lilly)|ABBV (AbbVie Inc) - Future Price to Earnings Multiple|Forward P/E Multiple AZN (AstraZeneca AB)|Future Price to Earnings Multiple NVS|MRK - Future Price to Earnings|Projected Price to Earnings Ratio novonordisk.com|Amgen (AMGN) - Future Price to Earnings|PFE (Pfizer Inc) - Future Price to Earnings|SNY (Sanofi Aventis) - Forward P/E Multiple|Price to Future Earnings Ratio BMY (Bristol-Myers Squibb Co.)|Forward P/E Multiple GSK|Market Cap to Projected Earnings takeda.com|Future Price to Earnings Teva Pharmaceutical Industries Limited TEVA|RDY: Price to Future Earnings Ratio|Viatris Corp - Forward P/E Multiple|Forward Price to Earnings Multiple Roivant Corp (ROIV)|ZLAB: Forward P/E Multiple|Projected Price to Earnings bauschhealth.com